GSK Investigational Site is a clinical research site located in Philadelphia, Pennsylvania, United States 19111.
Crixeo Clinical Trials Trust Score: 34/100 (FAILING). This profile has not yet been claimed by the site owner.
GSK Investigational Site has participated in 337 clinical trials with 35 currently active.
Therapeutic areas: Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumor (GIST), Digestive System Disease.
Sponsors: IDRX, Inc., a wholly owned subsidiary of GSK, LLC, GlaxoSmithKline, Human Genome Sciences Inc., a GSK Company.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Philadelphia
Trust Score: 34/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
GSK Investigational Site has a Crixeo Trust Score of 34/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
GSK Investigational Site has 337 clinical trials on record, with 35 currently active. Their work covers Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumor (GIST), Digestive System Disease.
GSK Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.